Diskets Tablet
NDC Package 0054-4538-25
Package Information
Diskets (methadone hydrochloride) tablets is a medication used to treat addiction to opioids (such as heroin) as part of an approved treatment program. This formulation utilizes a tablet delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0054-4538 and is authorized under FDA application NDA017058.
Identification & Billing
- RxCUI: 1990745 - DISKETS 40 MG Tablet for Oral Suspension
- RxCUI: 1990745 - methadone hydrochloride 40 MG Tablet for Oral Suspension [Diskets]
- RxCUI: 1990745 - Diskets 40 MG Tablet for Oral Suspension
- RxCUI: 864978 - methadone HCl 40 MG Tablet for Oral Suspension
- RxCUI: 864978 - methadone hydrochloride 40 MG Tablet for Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0054 - Hikma Pharmaceuticals Usa Inc.
- 0054-4538 - Diskets
- 0054-4538-25 - 100 TABLET in 1 BOTTLE, PLASTIC
- 0054-4538 - Diskets
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0054-4538-25 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Diskets, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains methadone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on March 14, 1973. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat addiction to opioids (such as heroin) as part of an approved treatment program. Methadone belongs to a class of drugs known as opioid analgesics. It helps prevent withdrawal symptoms caused by stopping other opioids.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00054453825. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.